| Year |
Citation |
Score |
| 2023 |
Leventhal JR, Galvin J, Ison MG, Feng CY, Ding R, Lee JR, Li C, Mathew JM, Gallon L, Gibson M, Belshe D, Tollerud DJ, Gornstein E, Suthanthiran M, Ildstad ST. Evaluation of Immunocompetence and Biomarkers of Tolerance in Chimeric and Immunosuppression-free Kidney Allograft Recipients. Transplantation. PMID 37370204 DOI: 10.1097/TP.0000000000004666 |
0.421 |
|
| 2015 |
Leventhal JR, Elliott MJ, Yolcu ES, Bozulic LD, Tollerud DJ, Mathew JM, Konieczna I, Ison MG, Galvin J, Mehta J, Badder MD, Abecassis MM, Miller J, Gallon L, Ildstad ST. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants. Transplantation. 99: 288-98. PMID 25594553 DOI: 10.1097/Tp.0000000000000605 |
0.363 |
|
| 2014 |
Leventhal J, Abecassis M, Miller J, Gallon L, Tollerud D, Elliot M, Ildstad S. Chimerism and Tolerance Without GVHD in Mismatched Recipients of Combined Hematopoietic Stem Cell/Kidney Transplants: Donor-Specific Hyporeactivity Is Not a Reliable Biomarker for Tolerance.: Abstract# C2094 Transplantation. 98: 900. DOI: 10.1097/00007890-201407151-03079 |
0.451 |
|
| 2014 |
Leventhal J, Abecassis M, Miller J, Gallon L, Galvin J, Mehta J, Ravindra K, Tollerud D, Elliot M, Ildstad S. Five Year Follow-Up of a Phase 2 Clinical Trial to Induce Tolerance in Mismatched Living Donor Renal Transplant Recipients.: Abstract# 2962 Transplantation. 98: 231. DOI: 10.1097/00007890-201407151-00689 |
0.429 |
|
| 2013 |
Leventhal J, Abecassis M, Miller J, Gallon L, Tollerud D, Elliott MJ, Bozulic LD, Houston C, Sustento-Reodica N, Ildstad ST. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome. Transplantation. 95: 169-76. PMID 23222893 DOI: 10.1097/Tp.0B013E3182782Fc1 |
0.469 |
|
| 2012 |
Leventhal J, Abecassis M, Miller J, Gallon L, Ravindra K, Tollerud DJ, King B, Elliott MJ, Herzig G, Herzig R, Ildstad ST. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation. Science Translational Medicine. 4: 124ra28. PMID 22399264 DOI: 10.1126/Scitranslmed.3003509 |
0.472 |
|
| 2009 |
Ildstad S, Cheerva A, Tollerud D, Bertolone S, Herzig G, Herzig R. Stable Mixed Chimerism After Non-Myeloablative Transplant for Sickle Cell Disease: Normal Hematopoiesis Dominates Over Abnormal In Mixed Chimerism Biology of Blood and Marrow Transplantation. 15: 79. DOI: 10.1016/J.Bbmt.2008.12.244 |
0.422 |
|
| 2000 |
Ildstad ST, Herzig R, Kaufman C, Crilley P, Brozena S, McCarthy P, Granger D, Jones J, Dowling R, Baxter-Lowe L, Tollerud D, Bentley F. SUMMARY OF A PHASE II PROTOCOL TO ATTEMPT TO INDUCE MIXED CHIMERISM AND DONOR-SPECIFIC TOLERANCE TO RENAL AND CARDIAC ALLOGRAFTS.: Abstract# 703 Transplantation. 69. DOI: 10.1097/00007890-200004271-00703 |
0.371 |
|
| 2000 |
Ildstad ST, Crilley P, Kaufman CL, Tollerud D, Cerrito P, Perry T, Shadduck R, Lister J, Champlin R, Wingard J, LeMaistre C, Kanz L, Topolsky D, Bashey A, Herzig R. A GRAFT ENGINEERING METHOD TO ALLOW BONE MARROW TRANSPLANTATION (BMT) FOR MORE HIGHLY MISMATCHED RECIPIENTS WITH LEUKEMIA: MULTIVARIATE ANALYSIS OF A PHASE I/II PROTOCOL.: Abstract# 702 Transplantation. 69. DOI: 10.1097/00007890-200004271-00702 |
0.388 |
|
| Show low-probability matches. |